These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1578709)

  • 21. Detecting and treating dyslipoproteinemias.
    Horlick L
    CMAJ; 1990 Oct; 143(7):607-9. PubMed ID: 2207913
    [No Abstract]   [Full Text] [Related]  

  • 22. Reduction of low density and high density lipoprotein cholesterol by fat-modified diets. A survey of recent findings.
    Vessby B; Lithell H; Boberg J
    Hum Nutr Clin Nutr; 1982; 36(3):203-11. PubMed ID: 6749766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and tolerability of long lasting LDL-apheresis in familial hyperlipoproteinemia.
    Bláha M; Cermanová M; Bláha V; Blazek M; Malý J; Siroký O; Solichová D; Filip S; Rehácek V
    Ther Apher Dial; 2007 Feb; 11(1):9-15. PubMed ID: 17309569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of type IIa and type V hyperlipoproteinemia and of a normal volunteer by continuous LDL-apheresis.
    Riesen WF; Sturzenegger E; Imhof C; Descoeudres C; Mordasini R; Oetliker OH
    Prog Clin Biol Res; 1988; 255():337-46. PubMed ID: 3422496
    [No Abstract]   [Full Text] [Related]  

  • 25. Plasma exchange and LDL apheresis.
    Thompson GR; Okabayashi K
    Prog Clin Biol Res; 1988; 255():311-6. PubMed ID: 3277202
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of procetofen on apolipoprotein A I and B concentrations in hyperlipoproteinemia.
    Viikari J; Solakivi-Jaakkola T; Lehtonen A
    Int J Clin Pharmacol Ther Toxicol; 1982 Aug; 20(8):362-5. PubMed ID: 6811447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipoproteins and apolipoproteins. Making use of their metabolic properties to individualize therapy.
    Kottke BA
    Postgrad Med; 1994 Feb; 95(2):51-3, 57-8, 63-5. PubMed ID: 8309863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Determination of LDL and beta-cholesterol in serum. Clinical significance and methodologic possibilities].
    Seidel D; Armstrong V; Cremer P
    Internist (Berl); 1987 Sep; 28(9):606-14. PubMed ID: 3312072
    [No Abstract]   [Full Text] [Related]  

  • 29. Direct adsorption of lipoproteins (DALI) from whole blood: first long-term clinical experience with a new LDL-apheresis system for the treatment of familial hypercholesterolaemia.
    Jansen M; Banyai S; Schmaldienst S; Goldammer A; Rohac M; Hörl WH; Derfler K
    Wien Klin Wochenschr; 2000 Jan; 112(2):61-9. PubMed ID: 10703153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of diet and drug therapy on the level of high density lipoprotein cholesterol in patients with primary hyperlipoproteinemia].
    Padosh D; Kustosh D; Puchok I; Dem'ianova N; Audikovski M
    Klin Med (Mosk); 1981 Sep; 59(9):45-8. PubMed ID: 7311430
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cholesterol and triglyceride content of lipoproteins in hyperlipoproteinemia type II/a, II/b and IV].
    Romics L; Karádi I; Simonyi E
    Orv Hetil; 1980 Oct; 121(43):2629-31. PubMed ID: 7208011
    [No Abstract]   [Full Text] [Related]  

  • 32. [Lipids and blood vessels].
    Drexel H; Amann FW
    Schweiz Rundsch Med Prax; 1993 Nov; 82(47):1344-7. PubMed ID: 8272699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lipoprotein metabolism and atherosclerosis--experimental principles].
    Hüttinger M; Dudczak R
    Vasa Suppl; 1987; 20():52-5. PubMed ID: 3480607
    [No Abstract]   [Full Text] [Related]  

  • 34. [Alcohol and hyperlipoproteinemia].
    Reuter W
    Z Arztl Fortbild (Jena); 1983; 77(7):290-3. PubMed ID: 6858231
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].
    Herrmann W; Reuter W
    Z Gesamte Inn Med; 1982 Dec; 37(24):830-3. PubMed ID: 6963524
    [No Abstract]   [Full Text] [Related]  

  • 36. [Apolipoproteins: their role in lipoprotein metabolism and the diagnostic value of their determination (literature review)].
    Titov VN; Cherniad'eva IF; Alamdarova IN; Osipov SG
    Lab Delo; 1983; (6):29-38. PubMed ID: 6193318
    [No Abstract]   [Full Text] [Related]  

  • 37. Reversible dyslipoproteinemia in patients with malaria is associated with a shortened prostaglandin I2 half-life in plasma.
    Efthimiou Y; Pirich C; Stomatopoulos J; O'Grady J; Sinzinger H
    Wien Klin Wochenschr; 1992; 104(22):705-6. PubMed ID: 1475977
    [No Abstract]   [Full Text] [Related]  

  • 38. [Basic principles of drug therapy of hyperlipoproteinemia].
    Romics L
    Orv Hetil; 1988 Nov; 129(45):2391-9. PubMed ID: 3054710
    [No Abstract]   [Full Text] [Related]  

  • 39. The physical structure of low-density lipoprotein in hyperlipoproteinemias and atherosclerosis.
    Bihari-Varga M; Gruber E; Tölgyesi F
    Monogr Atheroscler; 1986; 14():173-8. PubMed ID: 3736559
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical risk factors in coronary disease. The Framingham study].
    Castelli WP
    Wien Med Wochenschr; 1982; 132 Spec No 2():I-IX. PubMed ID: 7168181
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.